[HTML][HTML] COVID-19 2022 update: transition of the pandemic to the endemic phase

M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …

Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid

D Buonsenso, LD Gennaro, CD Rose… - Future …, 2022 - Taylor & Francis
There is limited evidence available on the long-term impact of SARS-CoV-2 infection in
children. In this article, the authors analyze the recent evidence on pediatric long Covid and …

[HTML][HTML] COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases

EK Sher, A Ćosović, A Džidić-Krivić, EK Farhat, E Pinjić… - Life sciences, 2023 - Elsevier
SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

[HTML][HTML] The SARS-CoV-2 S1 spike protein promotes MAPK and NF-kB activation in human lung cells and inflammatory cytokine production in human lung and …

CB Forsyth, L Zhang, A Bhushan, B Swanson, L Zhang… - Microorganisms, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic began in January 2020 in Wuhan,
China, with a new coronavirus designated SARS-CoV-2. The principal cause of death from …

Persistence of neutrophil extracellular traps and anticardiolipin auto‐antibodies in post‐acute phase COVID‐19 patients

E Pisareva, S Badiou, L Mihalovičová… - Journal of Medical …, 2023 - Wiley Online Library
In the early phase of the pandemic, we were among the first to postulate that neutrophil
extracellular traps (NETs) play a key role in COVID‐19 pathogenesis. This exploratory …

Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection

AA Hope, TH Evering - Infectious Disease Clinics, 2022 - id.theclinics.com
The clinical spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection ranges from asymptomatic to critical illness, which may include severe sepsis and …

[HTML][HTML] Long-term sequelae of COVID-19 in experimental mice

MJ Paidas, DS Cosio, S Ali, NS Kenyon… - Molecular …, 2022 - Springer
We recently reported acute COVID-19 symptoms, clinical status, weight loss, multi-organ
pathological changes, and animal death in a murine hepatitis virus-1 (MHV-1) coronavirus …

[HTML][HTML] Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets

X Liu, W Xiong, M Ye, T Lu, K Yuan, S Chang… - … and Targeted Therapy, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …

Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19

A Kumar, R Parashar, S Kumar, MA Faiq… - Journal of Medical …, 2022 - Wiley Online Library
Young age, female sex, absence of comorbidities, and prior infection or vaccination are
known epidemiological barriers for contracting the new infection and/or increased disease …

[HTML][HTML] Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

JP Gygi, C Maguire, RK Patel, P Shinde… - The Journal of …, 2024 - Am Soc Clin Investig
BACKGROUND Patients hospitalized for COVID-19 exhibit diverse clinical outcomes, with
outcomes for some individuals diverging over time even though their initial disease severity …